Advanced Medical Equipment & Technology

Cerner Corporation gives Q3 2014 guidance in line with analysts' estimates; raises low end of prior FY 2014 guidance

Cerner Corporation:Expects Q3 2014 revenue between $840 million and $870 million.Expects Q3 2014 adjusted diluted earnings per share before share based compensation expense between $0.41 and $0.42.Expects FY 2014 revenue between $3.3 billion and $3.4 billion, which is up from a prior range of $3.25...

Thursday, 24 Jul 2014 04:04pm EDT

Spectranetics Corp raises FY 2014 revenue guidance; lowers FY 2014 earnings guidance

Spectranetics Corp:Expects FY 2014 revenue to be in the range of $198.5 million to $201.0 million.Expects FY 2014 net loss to be in the range of $36.0 - $38.0 million, or $0.85 - $0.90 per share.Expects FY 2014 non-GAAP net loss to be in the range of $13.3 - $15.3 million, or $0.32 - $0.36 per...

Thursday, 24 Jul 2014 04:04pm EDT

Cynosure Inc receives expanded FDA clearance to Market PicoSure for Treatment of Acne Scars

Cynosure Inc:Announced that it has received FDA 510 clearance to market its PicoSure Picosecond Laser Workstation for the treatment of acne scars with the FOCUS lens array, the company's new disposable energy delivery system.

Thursday, 24 Jul 2014 08:30am EDT

MELA Sciences Inc announces new study results demonstrating improved diagnostic accuracy for resident dermatologists when utilizing MelaFind Predictive Probability Information

MELA Sciences Inc:Announced new study results demonstrating effectiveness of MelaFind predictive probability information when used by dermatology residents.Results strongly correlate with findings of similar, previously reported analysis on dermatologists' decisions to biopsy.Together, these studies...

Thursday, 24 Jul 2014 08:01am EDT

Mergers & Acquisitions

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.